Back to 
RA Capital Management, L.P.
RA Capital Management, L.P.
PCVX
Showing 8 of 25 quarters
Position history for RA Capital Management, L.P.'s holdings in Vaxcyte, Inc.
Yes. RA Capital Management holds 11,474,599 shares of PCVX (Vaxcyte), worth $667M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. RA Capital Management has held PCVX since Q2 2020, across 25 quarterly 13F filings. PCVX is 5.8% of RA Capital Management's reported 13F portfolio.
Current Value
$667M
Current Shares
11.5M
Total Value Change
-$325.9M
Total Shares Change
+2.8M
Quarter-by-Quarter History